News About: Pharm. Industry
Chuggei acquisition plan hit snag
The acquisition plan of Chunggei Pharmaceutical Co. was rejected by Schnell Life Science’s board of directors meeting on October 19 due to lack of a quorum, pharmaceutical sources said.
Last month, Schnell said in ...
Hanmi challenges against PfizerPfizer Korea filed a suit against Hanmi Pharmaceutical Co. at the Seoul Central District Court for patent infringement, claiming the latter’s Palpal tablet infringed Vigra’s tab...
|
Ildong registers Lactobacillus acidophilus tyndalized lyophilizates into DMF
Ildong Pharmaceutical Co. said it has recently registered a variety of Lactobacillus acidophilus IDCC3302 tyndalized lyophilizates into the drug master file (DMF), following its Lactobacillus acidophilus registration ...
Patent-linkage system is controversial
The country’s pharmaceutical companies face tough times ahead with the new Korea-U.S. Free Trade Agreement poised to strengthen patent rights for U.S. drug giants, heaping strain on the generic-focused Korean industry...
Pfizer Korea files suit against HanmiPfizer Korea has filed a patent suit against Hanmi Pharmaceutical Co., claiming the latter’s Viagra generic Palpal tablets imitated the design of blue magic pill.
The court s...
|
New hepatitis B drug to be released from December
Gilead Sciences’ Viread (tenofovir disoproxil fumarate) will be launched from December 1, according to Yuhan Corp., a local exclusive distributor.
Viread is indicated for the treatment of chronic hepatitis B in adu...
Roche Korea releases pen-type injection for PegasisRoche Korea has marketed Pegasys Proclick Autoinjector (peginterferon-2a) 180 μg and 135 μg since last month.
The autoinjector is a device that comes prefilled with a correct...
|
EZMedicom keeps top spot in GPO market
EZMedicom maintained the top spot in the domsetic GPO (Group Purchasing Organization), strengthening its presence, data showed Tuesday.
The company's share in the GPO market came to 53.6 percent with its sales of 6...
16 generic drugs overpriced, lawmaker claims
A lawmaker on Tuesday criticized domestic drug makers for overpricing 16 generic products in the domestic market.
During a parliamentary inspection of the Health Insurance Review and Assessment Service, Rep. Shin E...
Celltrion files patent application for new breast cancer drug
A local biopharmaceutical company has pushed up with its project to develop an ADR (antibody-drug conjugate) based breast cancer drug, paving the way for it to enter a new market with lucrative potential.
Celltrion...
